---
title: "Sana Biotechnology (SANA) Receives a Buy from Wedbush"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286278215.md"
description: "Wedbush analyst Martin Fan has maintained a Buy rating on Sana Biotechnology (SANA) with a price target of $7.00. Fan, a 5-star analyst with a 69.44% success rate, focuses on the Healthcare sector. Additionally, Bank of America Securities also reiterated a Buy rating on the stock with the same price target of $7.00."
datetime: "2026-05-13T14:18:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286278215.md)
  - [en](https://longbridge.com/en/news/286278215.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286278215.md)
---

# Sana Biotechnology (SANA) Receives a Buy from Wedbush

Wedbush analyst Martin Fan maintained a Buy rating on Sana Biotechnology today and set a price target of $7.00.

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

According to TipRanks, Fan is a 5-star analyst with an average return of 65.9% and a 69.44% success rate. Fan covers the Healthcare sector, focusing on stocks such as Nektar Therapeutics, Sana Biotechnology, and Oruka Therapeutics.

In a report released yesterday, Bank of America Securities also reiterated a Buy rating on the stock with a $7.00 price target.

### Related Stocks

- [SANA.US](https://longbridge.com/en/quote/SANA.US.md)
- [LABD.US](https://longbridge.com/en/quote/LABD.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [NKTR.US](https://longbridge.com/en/quote/NKTR.US.md)
- [ORKA.US](https://longbridge.com/en/quote/ORKA.US.md)
- [BAC.US](https://longbridge.com/en/quote/BAC.US.md)
- [BAC-Q.US](https://longbridge.com/en/quote/BAC-Q.US.md)
- [BML-L.US](https://longbridge.com/en/quote/BML-L.US.md)
- [BAC-L.US](https://longbridge.com/en/quote/BAC-L.US.md)
- [BAC-K.US](https://longbridge.com/en/quote/BAC-K.US.md)
- [BML-H.US](https://longbridge.com/en/quote/BML-H.US.md)
- [BAC-N.US](https://longbridge.com/en/quote/BAC-N.US.md)
- [BAC-E.US](https://longbridge.com/en/quote/BAC-E.US.md)
- [MER-K.US](https://longbridge.com/en/quote/MER-K.US.md)
- [BAC-O.US](https://longbridge.com/en/quote/BAC-O.US.md)
- [BML-G.US](https://longbridge.com/en/quote/BML-G.US.md)
- [BAC-M.US](https://longbridge.com/en/quote/BAC-M.US.md)
- [BAC-B.US](https://longbridge.com/en/quote/BAC-B.US.md)
- [BML-J.US](https://longbridge.com/en/quote/BML-J.US.md)
- [BAC-S.US](https://longbridge.com/en/quote/BAC-S.US.md)
- [BAC-P.US](https://longbridge.com/en/quote/BAC-P.US.md)
- [8648.JP](https://longbridge.com/en/quote/8648.JP.md)

## Related News & Research

- [Roth MKM Sticks to Their Buy Rating for Capricor Therapeutics (CAPR)](https://longbridge.com/en/news/286497683.md)
- [Leerink Partners Sticks to Their Buy Rating for Ibio (IBIO)](https://longbridge.com/en/news/286588262.md)
- [Acrivon Therapeutics, Inc. (ACRV) Receives a Buy from Oppenheimer](https://longbridge.com/en/news/286428001.md)
- [Analyst Reiterates Buy on Corbus, Maintains $38 Price Target on CRB-701 Oncology Potential](https://longbridge.com/en/news/286284525.md)
- [HC Wainwright Analysts Increase Earnings Estimates for CTMX](https://longbridge.com/en/news/286258226.md)